Loading
Latest filing published 19 May 2023 for PhaseBio Pharmaceuticals Inc. Read the official filing
No signal scores available.
Our data holds just one disclosure by Richard van den Broek, dated 19 May 2023, reporting a share grant in PhaseBio Pharmaceuticals Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration